Pretax income is the income that a company earns before paying income taxes. Sight Sciences's pretax income for the
three
months ended in Mar. 2024 was $-16.25 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-54.63 Mil.
Sight Sciences's pretax margin was -84.34%.
During the past 6 years, Sight Sciences's highest Pretax Margin was -67.04%. The lowest was -189.85%. And the median was -123.07%.
Sight Sciences Pre-Tax Income Historical Data
The historical data trend for Sight Sciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sight Sciences's Pre-Tax Income
For the Medical Devices subindustry, Sight Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sight Sciences's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sight Sciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Sight Sciences's Pre-Tax Income falls into.
Sight Sciences Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Sight Sciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-54.63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sight Sciences (NAS:SGHT) Pre-Tax Income Explanation
Sight Sciences's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 6 years, Sight Sciences's highest Pretax Margin was -67.04%. The lowest was -189.85%. And the median was -123.07%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sight Sciences Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Sight Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Sight Sciences (Sight Sciences) Business Description
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGHT has been successfully added to your 